Financial Year |
March 31 2023 |
Monetary Funds |
647,436,713.06 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
51,525,626.88 |
Accounts Receivable |
988,733,765.88 |
Advances to Suppliers |
50,474,429.38 |
Other Receivables |
260,515,199.90 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
240,994,856.02 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
212,224,698.79 |
Other Current Assets |
237,497,448.47 |
Total Current Assets |
3,376,290,450.99 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
110,654,667.28 |
Long-term Equity Investment |
60,777,245.55 |
Investment Properties |
67,686,900.72 |
Fixed Assetes |
239,964,439.56 |
Under-construction Projects |
4,423,985.53 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
556,916,856.09 |
R&D expenses |
-- |
Goodwill |
227,362,421.79 |
Long-Term Deferred and Prepaid Expenses |
4,884,177.51 |
Deferred Income Tax Assets |
224,345,164.53 |
Other Non-Current Assets |
6,142,132,663.77 |
Sub-Total of Non-Current Assets |
7,702,827,838.83 |
Total Assets |
11,079,118,289.82 |
Short-Term Loans |
1,043,703,123.85 |
Trading Financial liabilities |
-- |
Notes Payable |
34,505,820.72 |
Accounts Payable |
2,009,823,988.47 |
Accounts Received In Advance |
13,237,561.74 |
Employee Compensation Payable |
32,888,585.24 |
Taxes Payable |
17,030,104.44 |
Interest Payable |
-- |
Dividend Payable |
6,000,000.00 |
Other payables |
1,932,073,356.55 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
381,403,751.81 |
Other Current Liabilities |
123,968,931.75 |
Sub-Total of Current Liabilities |
5,747,793,396.00 |
Long-term Loans |
2,437,281,505.52 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
526,919,876.16 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
33,383,229.08 |
Other Non-Current Liabilities |
749,392,626.95 |
Sub-Total of Non-Current Liabilities |
3,765,720,656.85 |
Total Liabilities |
9,513,514,052.85 |
Paid-In Capital(Or Share Stock) |
1,553,807,314.00 |
Capital Surplus |
1,365,551,230.89 |
Surplus Reserve |
41,362,383.28 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-1,468,565,467.15 |
Minority Stockholder's Interest |
333,607,836.25 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,231,996,400.72 |
Owner's Equity(Stockholder's Equity) |
1,565,604,236.97 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
11,079,118,289.82 |